Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Mar;59(3):460-1.
doi: 10.1038/bjc.1989.94.

Oral contraceptives and primary liver cancer

Affiliations
Free PMC article

Oral contraceptives and primary liver cancer

C La Vecchia et al. Br J Cancer. 1989 Mar.
Free PMC article

Abstract

PIP: The relative risk for developing primary liver cancer in northern Italian users of oral contraceptives, compared to matched controls was calculated based on reported cases in hospitals in the greater Milan area from 1984-1987. The incidence of and mortality from primary liver cancer, as well as the prevalence of oral contraceptive usage, have both been rising to Italy since the late 1950s. 21 cases of liver cancer, in women aged 32-59 (median 50), occurred in the Milan area during the study period. These women, and 145 controls matched for age but admitted to hospitals for a variety of non-neoplastic diseases, were interviewed with a structured questionnaire covering socio-demographics, life style, diet, medical history, and history of use of oral contraceptives and other drugs. 19.0% of the cases had used oral contraceptives compared to 7.6% of controls, a relative risk of 1.8 for up to 5 years' use, and 8.3 for 5 years. History of hepatitis was associated with 14% of cases and 7% of controls. Italians have a higher incidence of liver neoplasms that northern Europeans and Americans, probably because of higher incidence of risk factors, such as hepatitis and alcohol use. The attributable risk for oral contraception, however, is lower in this population.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1980 Oct;40(10):3680-5 - PubMed
    1. J Surg Oncol. 1981;18(1):73-85 - PubMed
    1. Br J Cancer. 1983 Sep;48(3):349-54 - PubMed
    1. Br J Cancer. 1983 Sep;48(3):437-40 - PubMed
    1. Int J Cancer. 1988 Dec 15;42(6):872-6 - PubMed

Publication types

Substances